UPDATE: Morgan Stanley Reiterates on Walgreen Company on 2QFY14 Earnings Preview
In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company (NYSE: WAG), but removed the $68.00 price target.
In the report, Morgan Stanley noted, “WAG shares up 17% since January and holding on to gains March to-date, heading into what is likely to be soft earnings as investors focus on LT opportunities. Key to share performance will be mgmt commentary regarding synergies, timing of step 2 of AB deal, and strategic direction.”
Walgreen Company closed on Tuesday at $67.20.
Latest Ratings for WAG
|Dec 2014||SunTrust Robinson Humphrey||Downgrades||Buy||Neutral|
|Dec 2014||Deutsche Bank||Maintains||Buy|
|Dec 2014||Citigroup||Initiates Coverage on||Buy|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.